Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial
达罗鲁胺治疗日本非转移性去势抵抗性前列腺癌患者的疗效和安全性：III期ARAMIS试验的亚组分析
期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-020-01824-5
Uemura, Hiroji; Matsushima, Hisashi; Kobayashi, Kazuki; Mizusawa, Hiroya; Nishimatsu, Hiroaki; Fizazi, Karim; Smith, Matthew; Shore, Neal; Tammela, Teuvo; Tabata, Ken-Ichi; Matsubara, Nobuaki; Iinuma, Masahiro; Uemura, Hirotsugu; Oya, Mototsugu; Momma, Tetsuo; Kawakita, Mutsushi; Fukasawa, Satoshi; Kobayashi, Tadahiro; Kuss, Iris; Le Berre, Marie-Aude; Snapir, Amir; Sarapohja, Toni; Suzuki, Kazuhiro
